Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1996 Jun;10(3):368-73.
doi: 10.1007/BF00866789.

Renal involvement in mitochondrial cytopathies

Affiliations
Review

Renal involvement in mitochondrial cytopathies

P Niaudet et al. Pediatr Nephrol. 1996 Jun.

Abstract

Mitochondrial cytopathies have long been regarded as neuromuscular diseases. However, an oxidative phosphorylation disorder may give rise to various symptoms in other organs or tissues which are dependent upon mitochondrial energy supply. A broad spectrum of clinical symptoms have been described in these patients, including renal symptoms. The most frequent is proximal tubular dysfunction with a more or less complete de Toni-Debré-Fanconi syndrome. A few patients have been reported with tubular acidosis, Bartter syndrome, chronic tubulointerstitial nephritis, or nephrotic syndrome. The diagnosis of a respiratory chain deficiency is difficult when only renal symptoms are present but should be easier when another seemingly unrelated symptom is observed. Metabolic screening for abnormal oxidoreduction status in plasma, including lactate/pyruvate and ketone body molar ratios, can help to identify patients for further investigations. These include the measurement of oxygen consumption by mitochondria, the assessment of mitochondrial respiratory enzyme activities by spectrophotometric studies, and, when possible, the molecular analysis of mitochondrial DNA. Any mode of inheritance can be observed: sporadic, autosomal dominant or recessive, or maternal inheritance. No satisfactory therapy is presently available for mitochondrial disorders.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Pediatr Res. 1977 Oct;11(10 Pt 2):1088-93 - PubMed
    1. Am J Hum Genet. 1992 Feb;50(2):364-70 - PubMed
    1. Nature. 1981 Apr 9;290(5806):457-65 - PubMed
    1. Pediatr Pathol. 1985;4(1-2):25-35 - PubMed
    1. J Pediatr. 1975 Jun;86(6):873-80 - PubMed

MeSH terms

Substances

LinkOut - more resources